Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

15.8%

3 terminated/withdrawn out of 19 trials

Success Rate

70.0%

-16.5% vs industry average

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
9(52.9%)
Phase 2
5(29.4%)
Phase 1
2(11.8%)
Phase 3
1(5.9%)
17Total
N/A(9)
Phase 2(5)
Phase 1(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT04765514Phase 2Recruiting

Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients

Role: collaborator

NCT03938987Phase 1Recruiting

Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)

Role: collaborator

NCT04448184Phase 3Recruiting

Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)

Role: collaborator

NCT03469011Phase 1Terminated

A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

Role: collaborator

NCT03737721Phase 2Terminated

The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy

Role: collaborator

NCT03957252Active Not Recruiting

Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer

Role: collaborator

NCT05190653Not ApplicableRecruiting

Early Integration of Palliative and Supportive Care in Cellular Therapy

Role: collaborator

NCT04107103Phase 2Completed

Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma

Role: collaborator

NCT04698499Not ApplicableCompleted

Swallowing Therapy With the Assistance of a Mobile Health Device in Head and Neck Cancer Patients: a Pan-Alberta Study

Role: collaborator

NCT04831190Not ApplicableUnknown

A Tailored Exercise Oncology Program for Neuro-Oncology Patients

Role: collaborator

NCT05649371Not ApplicableUnknown

Multiphasic Prehab Allo-HSCT

Role: collaborator

NCT02385812Phase 2Terminated

Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma

Role: collaborator

NCT03572101Completed

Living With Colorectal Cancer: Patient and Caregiver Experience

Role: collaborator

NCT03456167Not ApplicableCompleted

Mobile App Postoperative Home Monitoring After Enhanced Recovery Oncologic Surgery

Role: collaborator

NCT02431962Not ApplicableUnknown

Alberta Lung Cancer Screening Program

Role: collaborator

NCT02681107Not ApplicableUnknown

APBI: 27Gy in 5 Fractions for Early Breast Cancer

Role: collaborator

NCT01681654Not ApplicableCompleted

Exercise and Nutrition for Head and Neck Cancer Patients

Role: collaborator

NCT00322985Phase 2Completed

A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma

Role: collaborator

NCT00156871Not ApplicableCompleted

Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant (HSCT)

Role: collaborator

All 19 trials loaded